baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Alimera Sciences Inc/ US0162592028 /

2024-04-16 8:51:42 PM	Chg. +0.0300	Volume	Bid8:52:27 PM	Ask8:52:27 PM	High	Low
3.5700USD	+0.85%	36,424 Turnover: 114,405.0846	3.5500Bid Size: 600	3.6100Ask Size: 200	3.7400	3.5300

GlobeNewswire 03-20 Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 03-19 Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRC...

GlobeNewswire 03-19 Repligen Appoints Maggie A. Pax to Board of Directors

GlobeNewswire 03-07 Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results

GlobeNewswire 02-29 Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and...

GlobeNewswire 02-08 The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provi...

GlobeNewswire 01-04 Alimera Completes Recruitment for the Synchronicity Study

GlobeNewswire 01-02 Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Na...

GlobeNewswire 2023-12-12 Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Und...

GlobeNewswire 2023-11-08 Alimera Appoints Maggie A. Pax to Its Board of Directors

GlobeNewswire 2023-11-01 EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporat...

GlobeNewswire 2023-10-31 Alimera Announces Scientific Data Highlighting ILUVIEN® To Be Presented at the American Academy of O...

GlobeNewswire 2023-10-26 Alimera Sciences Reports Third Quarter 2023 Results

GlobeNewswire 2023-10-16 Alimera Sciences to Report Third Quarter 2023 Financial Results on October 26, 2023, and Provide Cor...

GlobeNewswire 2023-10-16 EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team

GlobeNewswire 2023-10-11 Alimera Announces Multiple Presentations Highlighting ILUVIEN® and YUTIQ® Data at Retina Society Ann...

GlobeNewswire 2023-10-03 Alimera Sciences Appoints Jason Werner as Chief Operating Officer

GlobeNewswire 2023-09-11 EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 i...

GlobeNewswire 2023-09-05 Alimera Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire 2022-03-02 Alimera Sciences to Present at the Q1 Investor Summit Conference

GlobeNewswire 2022-02-24 Alimera Sciences Reports Fourth Quarter and FY 2021 Results

GlobeNewswire 2022-02-17 Alimera Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, February...

GlobeNewswire 2022-02-07 Alimera Sciences Announces Launch of ILUVIEN® for Uveitis in Spain

GlobeNewswire 2022-02-04 Alimera Sciences to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conf...

GlobeNewswire 2022-01-05 Alimera Sciences to Participate in Upcoming January 2022 Investor Conferences

Alimera Sciences Inc/ US0162592028 /

If you wish to receive reply to your feedback, please provide your email address.